My 5 Stock Watchlist This Week

Plus Monday’s #1 Runner! ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌   Hey folks, Tim here. Please excuse the late watchlist. These stocks usually are sent to your inbox on Sunday. This list got lost in the works last weekend. And we’ve taken steps to get back on track. But … Every cloud has a silver lining. Because you’re receiving this watchlist on Monday, I have the ability to confirm Monday’s hottest runner. Keep an eye on this stock all week! Summit Therapeutics Inc. (NASDAQ: SMMT) was already a multi-month runner … But on Monday morning the market learned its lung cancer treatment, Ivonescimab Monotherapy, showed greater efficacy (by 49%) when compared to the previous leading treatment, Pembrolizumab Monotherapy. This is a big catalyst … And if you don’t believe me, take a look at the 70% spike already today. On the chart below, every candle represents one trading day: SMMT chart multi-month, 1-day candles Source: StocksToTrade SMMT is a larger-cap stock, compared to some of the other runners on today’s watchlist. That means it’s a prime candidate for a swing-trade setup. The lung-cancer news is an extremely bullish catalyst, but this volatility can still be dangerous for new traders. Make sure you’re following a trading plan! Our AI swing-trading bot follows my specific trading process for these large-cap runners. [Use Iris to build a smart position on SMMT.]( The volatility is already rampant on Monday! I’ve got a 5-stock watchlist to ensure you’re prepared for the runners that are still in play. [Click HERE For My Full Watchlist]( P.S. Attention beginner traders: There’s no need to complicate things right now, focus on the #1 trading strategy in the market right now! All it takes is one good setup. There’s a live tutorial this week on Thursday at 6PM Eastern. [Reserve your spot!]( Stay steady, Tim Bohen SteadyTrade Team Lead Trainer     Recommended Membership Gift   ACCESS NOW: Click below to activate exclusive content and daily market intel from our market pros. Exclusive]( Analysis and]( Videos](     [Facebook]( [Twitter]( [Instagram]( [YouTube]( [Spotify]( [Click Here to Unsubscribe]( (As an Amazon Associate, we earn from qualifying purchases.) 13809 Research Boulevard, Suite 500, Austin, TX 78750 *Please note that these kinds of trading results are not typical. Most traders lose money. It takes years of dedication, hard work, and discipline to learn how to trade, and individual results will vary. Trading is inherently risky. Before making any trades, remember to do your due diligence and never risk more than you can afford to lose. This is for informational purposes only as StocksToTrade is not registered as a securities broker-dealer or an investment adviser. No information herein is intended as securities brokerage, investment, tax, accounting or legal advice, as an offer or solicitation of an offer to sell or buy, or as an endorsement, recommendation or sponsorship of any company, security or fund. StocksToTrade cannot and does not assess, verify or guarantee the adequacy, accuracy or completeness of any information, the suitability or profitability of any particular investment, or the potential value of any investment or informational source. The reader bears responsibility for his/her own investment research and decisions, should seek the advice of a qualified securities professional before making any investment, and investigate and fully understand any and all risks before investing. StocksToTrade in no way warrants the solvency, financial condition, or investment advisability of any of the securities mentioned in communications or websites. In addition, StocksToTrade accepts no liability whatsoever for any direct or consequential loss arising from any use of this information. This information is not intended to be used as the sole basis of any investment decision, should it be construed as advice designed to meet the investment needs of any particular investor. Past performance is not necessarily indicative of future returns. Copyright © StocksToTrade.com